Essential Brilliant Violet 421™ Anti-human Cd137l (4-1bb Ligand) Tool [fMcZ7Drw]
Brilliant Violet 421™ Anti-human CD137L (4-1BB Ligand) Discover the power of our Essential Brilliant Violet 421™ Anti-human Cd137l (4-1bb Ligand) Tool [fMcZ7Drw] antibody, a cutting-edge tool for studying T cell proliferation and cytokine production. This monoclonal antibody,
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
Brilliant Violet 421™ Anti-human CD137L (4-1BB Ligand)
Discover the power of our Essential Brilliant Violet 421™ Anti-human Cd137l (4-1bb Ligand) Tool [fMcZ7Drw] antibody, a cutting-edge tool for studying T cell proliferation and cytokine production. This monoclonal antibody, clone 5F4, offers exceptional specificity and sensitivity, making it an ideal choice for your research needs.Product Details
Our anti-human CD137L antibody is produced in mouse and conjugated to BV421, a vibrant fluorochrome that provides excellent signal-to-noise ratio. This antibody recognizes and binds to human CD137L, a 97 kD member of the TNF superfamily expressed on APCs, activated B, and T cells. Key features include:- Reactivity: Human
- Format: BV421 conjugated
- Host: Mouse
- Isotype: IgG1, κ
Applications and Benefits
This antibody is ideal for flow cytometry applications, providing reliable and consistent results. Its ability to act as a costimulatory molecule without the engagement of other costimulatory molecules like CD28 makes it a valuable tool in your research. Here are some of the practical uses and benefits:- Flow Cytometry: Quality tested for flow cytometry applications
- Research Focus: T cell proliferation and cytokine production studies
- Target Audience: Researchers in immunology, oncology, and related fields
What Our Customers Say
Absolutely no complaints!
The product is a very good quality set.
- Yara C..
Absolutely no complaints!
It's a very well-made product, great quality and very efficient.
- Elora P..
Absolutely no complaints!
This is a product that is well worth the money.
- Theodore F..